Oral Hypoglycemic agents Flashcards

1
Q

Sulfonylureas: MOA

A

Increase insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sulfonylureas disadvantage

A

Hypoglycemia
Wt gain
inhibit MI
B cell exhaustion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Names of sulfonylurease

A

1st gen: Chlorpropamide
2nd gen: Glipizide
glyburide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

name of Biguanide

A

Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Biguanides MOA

A

Decrease helpatic glucose production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Biguanide advantage

A

Wt loss
no hypoglycemia
decrease cardiovascular risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Biguanide disadvangages

A

GI upsed
B12 deficiency
CKD contradiction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Thiazolidinediones drugs

A

Rosiglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Thiazolidinedionase MOA

A

Increase Peripheral insulin sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Disadvantage to Thiazolidineodinase

A

Wt gain
Edema, heart failure
bone fracture, LDL CVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Advantages for thiazilidneodinase

A

No hypoglycemia
Beta cell preservaton
increase HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Glinides drugs

A

Repaglinide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA of Glinides

A

iincrease insuline secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

advantage of glinides

A

decrease postprandial glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Disadvangage of glinides

A

B cell exhaustion
hypoglycemia
wt gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Alpah glucosidase inhibitors MOA

A

Decrease intestinal carbohydrate absorption

17
Q

GLIP-1 receptor agonist MOA

A

Increase insulin secretion
Decrease glucagon
increase satitety

18
Q

GLIP-1 receptor agonist

A

wt loss,

injectable

19
Q

Amylin mimetics moa

A

Activates amylin receptors
Reduce glucagon secretion
slow gastric emptying
increased satiety

20
Q

Amylin Mimetics drug

A

pramlintide

21
Q

DPP-4 inhibitors drug

A

sitagliptin

22
Q

DPP-4 inhibitor MMA

A

Inhibit DPP-4
increase endogenous incretions
increase insulin secretion
Decrease glucagon

23
Q

Bile acid sequestrants drug

A

golesevelam

24
Q

bile acid sequestrants moa

A

Binds bile acid cholesterol

25
what DM drugs do not have hypoglycemia
Bile acid sequestrants DPP-4 inhibitors Thiazolidinediones Biguanides
26
Insulin
genetic ingeneraion
27
Types of insuline
Regular: short acting SUBQ Rapid Acting: Lispro, aspart Intermediate: Long acting
28
Short acting insulin
Regular: pease 50-120 min | last 508 hours
29
Rapid acting insulin
peak 30-90 min
30
Intermediate acting
Onset 1-3 horus, | Lasts 16-24 hours
31
Ling acting
Slow release over 18-26 hours